2022
DOI: 10.1016/j.envadv.2022.100265
|View full text |Cite
|
Sign up to set email alerts
|

Current developments in biodosimetry tools for radiological/nuclear mass casualty incidents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…Biochemical biomarkers of radiation exposure have been developed as an alternative or supplementary method for detecting radiation exposure 10 . They include transcriptomic and proteomic biomarkers that are activated as part of the damage response pathways after radiation exposure including DNA repair, cell cycle functions and apoptosis 11 . However, there are several limitations including the relatively long processing time of cytogenetic based dosimetry (from days to one week), the need for invasive blood collections and the limited sensitivity in the low dose radiation range (< 1 Gy).…”
Section: Introductionmentioning
confidence: 99%
“…Biochemical biomarkers of radiation exposure have been developed as an alternative or supplementary method for detecting radiation exposure 10 . They include transcriptomic and proteomic biomarkers that are activated as part of the damage response pathways after radiation exposure including DNA repair, cell cycle functions and apoptosis 11 . However, there are several limitations including the relatively long processing time of cytogenetic based dosimetry (from days to one week), the need for invasive blood collections and the limited sensitivity in the low dose radiation range (< 1 Gy).…”
Section: Introductionmentioning
confidence: 99%